Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters











Database
Language
Publication year range
1.
Obes Rev ; 12(11): 984-94, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21729236

ABSTRACT

Bariatric surgery is the most effective method for promoting dramatic and durable weight loss in morbidly obese subjects. Furthermore, type 2 diabetes is resolved in over 80% of patients. The mechanisms behind the amelioration in metabolic abnormalities are largely unknown but may be due to changes in energy metabolism, gut peptides and food preference. The goal of this meeting was to review the latest research to better understand the mechanisms behind the 'magic' of bariatric surgery. Replication of these effects in a non-surgical manner remains one of the ultimate challenges for the treatment of obesity and diabetes. Promising data on energy metabolism, gastrointestinal physiology, hedonic response and food intake were reviewed and discussed.


Subject(s)
Bariatric Surgery/methods , Energy Metabolism/physiology , Obesity, Morbid/surgery , Weight Loss , Ghrelin/metabolism , Glucagon-Like Peptide 1/metabolism , Humans , Obesity, Morbid/metabolism , Peptide YY/metabolism , Weight Loss/physiology
2.
J Neuroendocrinol ; 19(3): 163-71, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17280589

ABSTRACT

Like lactating mammals, male and female ring dove parents increase their food consumption to meet the energetic challenges of provisioning their young. To clarify the neurochemical mechanisms involved, the present study investigated the relationship between parental hyperphagia and changes in activity of the potent orexigen neuropeptide Y (NPY) in the hypothalamus of breeding doves. Changes in NPY-immunoreactive (NPY-ir) cell numbers in the tuberal hypothalamus of male and female doves were examined by immunocytochemistry at six stages of the breeding cycle. Parallel NPY mRNA measurements were recorded in mediobasal hypothalamus (which includes the tuberal hypothalamus) by semiquantitative reverse transcription-polymerase chain reaction using 18S rRNA as the internal standard. NPY mRNA changes were also measured in the mediobasal hypothalamus of nonbreeding doves following intracranial administration of prolactin, an orexigenic hormone that is elevated in the plasma of parent doves, and in response to food deprivation, which mimics the negative energy state that develops in parents as they provision their growing young. NPY-ir cell numbers in the tuberal hypothalamus and NPY mRNA levels in the mediobasal hypothalamus were significantly higher in breeding males and females during the period of parental hyperphagia after hatching than during the late incubation period when food intake remains unchanged. In nonbreeding doves, food deprivation and prolactin treatment increased NPY mRNA in this region by two- to three-fold, which suggests that NPY expression is sensitive to hormonal and metabolic signals associated with parenting. We conclude that NPY synthesis is increased in the mediobasal hypothalamus during the posthatching period, which presumably supports increased NPY release and resulting parental hyperphagia. NPY-ir and mRNA were also high in the mediobasal hypothalamus prior to egg laying when food intake remained unchanged. Several lines of evidence suggest that this elevation in NPY supports the increased gonadal activity that accompanies intense courtship and nest building interactions in breeding doves.


Subject(s)
Columbidae/metabolism , Hyperphagia/metabolism , Hypothalamus/metabolism , Neuropeptide Y/biosynthesis , Reproduction/physiology , Animals , Energy Metabolism/physiology , Feeding Behavior/physiology , Female , Gene Expression Regulation/physiology , Gonads/physiology , Hypothalamo-Hypophyseal System/physiology , Male , Maternal Behavior/physiology , Neuropeptide Y/genetics , Paternal Behavior , Prolactin/physiology , RNA, Messenger/analysis , Statistics, Nonparametric
3.
J Neuroendocrinol ; 15(11): 1046-53, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14622434

ABSTRACT

Ring doves (Streptopelia risoria) exhibit marked increases in food consumption and decreases in body weight when they are provisioning their young. This study examined changes in hypothalamic immunostaining for agouti-related peptide (AGRP), an endogenous melanocortin receptor antagonist and appetite stimulant, during the ring dove breeding cycle. Because prolactin is orexigenic in doves, and is elevated in blood at the onset of parental hyperphagia, we also explored the possibility that prolactin-induced hyperphagia is associated with AGRP changes. The numbers of AGRP-immunoreactive (ir) cells within the tuberal hypothalamus were maximal during the prelaying period of the breeding cycle but decreased dramatically during early incubation. AGRP-ir cell numbers began to increase again during late incubation and reached a peak during the early and late posthatching stages. Because posthatching elevations in AGRP-ir were temporally associated with marked elevations in parental food intake, and because AGRP is orexigenic in doves, these findings suggest that increased AGRP activity in the dove tuberal hypothalamus may contribute to parental hyperphagia. Rising prolactin secretion during late incubation and early posthatching may initiate this increase in AGRP-ir, since intracerebroventricular administration of prolactin significantly elevated food intake and AGRP-ir cell numbers in the tuberal hypothalamus of nonbreeding doves. Prolactin-induced elevations in AGRP-ir cell numbers persisted when the confounding effects of weight gain that accompany prolactin-induced hyperphagia in nonbreeding doves were eliminated by a food restriction procedure, thereby suggesting that prolactin can directly influence AGRP activity under neutral energy state conditions.


Subject(s)
Columbidae/physiology , Hyperphagia/metabolism , Hypothalamus/metabolism , Prolactin/metabolism , Proteins/metabolism , Receptors, Melanocortin/antagonists & inhibitors , Reproduction/physiology , Agouti-Related Protein , Animals , Feeding Behavior/physiology , Female , Hypothalamus/cytology , Immunohistochemistry , Intercellular Signaling Peptides and Proteins , Male , Maternal Behavior/physiology , Nesting Behavior/physiology , Neurons/metabolism , Paternal Behavior , Receptors, Melanocortin/metabolism
4.
J Neuroendocrinol ; 13(4): 386-92, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11264727

ABSTRACT

Although neuropeptide-Y (NPY) has been widely reported to be a potent stimulator of feeding activity and regulator of energy homeostasis, most of the supportive evidence for such effects has been gathered in mammalian species. This study characterized the orexigenic potency of NPY in an avian species, the ring dove, and measured changes in hypothalamic NPY-immunoreactive (NPY-ir) cell numbers in response to energy state fluctuations or intracranial administration of the potent orexigenic hormone prolactin. Food intake was significantly elevated in male doves at 1 h after intracerebroventricular (i.c.v.) injection of 0.25 and 0.5 microg NPY but not after injection of a higher dose (1.0 microg). In time course studies, food intake was increased at 1 h after i.c.v. injection of 0.5 microg NPY but was not elevated at 2, 3, or 4 h. The number of NPY-ir cell bodies in the infundibular region of the dove hypothalamus increased two to four-fold following acute food deprivation, chronic food restriction, or repeated i.c.v. injections of prolactin. No additive effects were observed when food restriction and prolactin treatment were combined. These findings suggest that NPY is involved in energy homeostasis in doves and are consistent with the hypothesis that prolactin-induced hyperphagia is mediated in part by NPY.


Subject(s)
Columbidae/metabolism , Energy Metabolism/physiology , Feeding Behavior/physiology , Neuropeptide Y/metabolism , Prolactin/metabolism , Animals , Cell Count , Eating/drug effects , Energy Metabolism/drug effects , Feeding Behavior/drug effects , Food Deprivation/physiology , Hypothalamus/cytology , Hypothalamus/drug effects , Hypothalamus/metabolism , Injections, Intraventricular , Male , Neurons/cytology , Neurons/drug effects , Neurons/metabolism , Neuropeptide Y/administration & dosage , Prolactin/administration & dosage
5.
Biochemistry ; 39(23): 6898-909, 2000 Jun 13.
Article in English | MEDLINE | ID: mdl-10841771

ABSTRACT

Activation of G protein coupled receptors (GPCRs) by binding of ligand is the initial event in diverse cellular signaling pathways. To examine the frequency and diversity of mutations that cause constitutive activation of one particular GPCR, the yeast alpha-factor receptor, we screened libraries of random mutations for constitutive alleles. In initial screens for mutant receptor alleles that exhibit signaling in the absence of added ligand, 14 different point mutations were isolated. All of these 14 mutants could be further activated by alpha-factor. Ten of the mutants also acquired the ability to signal in response to binding of desTrp(1)¿Ala(3)alpha-factor, a peptide that acts as an antagonist toward normal alpha-factor receptors. Of these 10 mutants, at least eight alleles residing in the third, fifth, sixth, and seventh transmembrane segments exhibit bona fide constitutive signaling. The remaining alleles are hypersensitive to alpha-factor rather than constitutive. They can be activated by low concentrations of endogenous alpha-factor present in MATa cells. The strongest constitutively active receptor alleles were recovered multiple times from the mutational libraries, and extensive mutagenesis of certain regions of the alpha-factor receptor did not lead to recovery of any additional constitutive alleles. Thus, only a limited number of mutations is capable of causing constitutive activation of this receptor. Constitutive and hypersensitive signaling by the mutant receptors is partially suppressed by coexpression of normal receptors, consistent with preferential association of the G protein with unactivated receptors.


Subject(s)
Peptides/metabolism , Receptors, Peptide/genetics , Saccharomyces/metabolism , Transcription Factors , Amino Acid Sequence , Fungal Proteins/genetics , GTP-Binding Proteins/metabolism , Gene Library , Genes, Reporter , Lac Operon , Mating Factor , Membrane Proteins/genetics , Membrane Proteins/metabolism , Molecular Sequence Data , Mutagenesis , Peptides/pharmacology , Plasmids , Point Mutation , Protein Binding , Receptors, Mating Factor , Receptors, Peptide/metabolism , Saccharomyces/genetics , Signal Transduction
6.
Cell Biochem Biophys ; 33(3): 297-308, 2000.
Article in English | MEDLINE | ID: mdl-11325047

ABSTRACT

Conformations of ribostamycin and isepamicin, aminoglycoside antibiotics, bound to an aminoglycoside antibiotic, 3'-phosphotransferase, were determined by transferred nuclear Overhauser effect spectroscopy and molecular modeling. Two major conformers of enzyme-bound ribostamycin, a neomycin-group aminoglyeoside were observed. The 3'- and 5"-OH groups (reactive hydroxyl groups) in the conformers are placed in approximate locations. One of the conformers is similar to the structure of paromomycin bound to a 27-nucleotide piece of ribosomal RNA that represents the A-site of the small ribosomal subunit, where rings A and C are in an orthogonal arrangement. Isepamicin, a kanamycin-group aminoglycoside antibiotic, also showed two major enzyme-bound conformations. Both conformations were similar to those observed for bound isepamicin in the active site of an aminoglycoside(6')-acetyl transferase-Ii. Conformations of other RNA-bound kanamycin-group aminoglycosides were also similar to the enzyme-bound conformations of isepamicin. These observations suggest that aminoglycosides may adopt similar conformations when bound to RNA and protein targets. This may have significant implications in the design of enzyme inhibitors and/or antibiotics.


Subject(s)
Kanamycin Kinase/chemistry , Kanamycin/chemistry , RNA, Ribosomal/chemistry , Ribostamycin/chemistry , Animals , Kanamycin/metabolism , Kanamycin Kinase/metabolism , Nucleic Acid Conformation , Protein Binding , Protein Conformation , RNA, Ribosomal/metabolism , Ribostamycin/metabolism , Substrate Specificity
SELECTION OF CITATIONS
SEARCH DETAIL